Abstract
The “golden era” of antibiotic discovery has long passed, but the need for new antibiotics has never been greater due to the emerging threat of antibiotic resistance. This urgency to develop new antibiotics has motivated researchers to find new methods to combat pathogenic microorganisms resulting in a surge of research focused around antimicrobial peptides (AMPs; also termed host defense peptides) and their potential as therapeutics. During the past few decades, more than 2000 AMPs have been identified from a diverse range of organisms (animals, fungi, plants, and bacteria). While these AMPs share a number of common features and a limited number of structural motifs; their sequences, activities, and targets differ considerably. In addition to their antimicrobial effects, AMPs can also exhibit immunomodulatory, anti-biofilm, and anticancer activities. These diverse functions have spurred tremendous interest in research aimed at understanding the activity of AMPs, and various protocols have been described to assess different aspects of AMP function including screening and evaluating the activities of natural and synthetic AMPs, measuring interactions with membranes, optimizing peptide function, and scaling up peptide production. Here, we provide a general overview of AMPs and introduce some of the methodologies that have been used to advance AMP research.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Steiner H, Hultmark D, Engström Å et al (1981) Sequence and specificity of two antibacterial proteins involved in insect immunity. Nature 292:246–248
Zasloff M (1987) Magainins, A class of antimicrobial peptides from xenopus skin - isolation, characterization of 2 active forms, and partial cDNA sequence of a precursor. Proc Natl Acad Sci 84:5449–5453
Zasloff M (2002) Antimicrobial peptides of multicellular organisms. Nature 415:389–395
Mookherjee N, Hancock REW (2007) Cationic host defence peptides: innate immune regulatory peptides as a novel approach for treating infections. Cell Mol Life Sci 64:922–933
Hancock REW, Scott MG (2000) The role of antimicrobial peptides in animal defenses. Proc Natl Acad Sci 97:8856–8861
Lai JR, Huck BR, Weisblum B, Gellman SH (2002) Design of non-cysteine-containing antimicrobial β-hairpins: structure–activity relationship studies with linear protegrin-1 analogues. Biochemistry 41:12835–12842
Gallo RL, Hooper LV (2012) Epithelial antimicrobial defence of the skin and intestine. Nat Rev Immunol 12:503–516
Faurschou M, Borregaard N (2003) Neutrophil granules and secretory vesicles in inflammation. Microbes Infect 5:1317–1327
Jenssen H, Hamill P, Hancock REW (2006) Peptide antimicrobial agents. Clin Microbiol Rev 19:491–511
Phoenix DA, Dennison SR, Harris F (2013) Anionic antimicrobial peptides. In: Antimicrobial peptides. Wiley-VCH, GmbH & Co. KGaA, pp 83–113
Hancock REW, Sahl HG (2006) Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies. Nat Biotechnol 24:1551–1557
Nguyen LT, Haney EF, Vogel HJ (2011) The expanding scope of antimicrobial peptide structures and their modes of action. Trends Biotechnol 29:464–472
Waghu FH, Barai RS, Gurung P, Idicula-Thomas S (2015) CAMPR3: a database on sequences, structures and signatures of antimicrobial peptides. Nucleic Acids Res 44:D1094–D1097
Piotto SP, Sessa L, Concilio S, Iannelli P (2012) YADAMP: yet another database of antimicrobial peptides. Int J Antimicrob Agents 39:346–351
Hammami R, Hamida JB, Vergoten G, Fliss I (2009) PhytAMP: a database dedicated to antimicrobial plant peptides. Nucleic Acids Res 37:D963–D968
Wang Z, Wang G (2004) APD: the antimicrobial peptide database. Nucleic Acids Res 32:D590–D592
Wang G, Li X, Wang Z (2015) APD3: the antimicrobial peptide database as a tool for research and education. Nucleic Acids Res 44:D1087–D1093
Skalickova S, Heger Z, Krejcova L et al (2015) Perspective of use of antiviral peptides against influenza virus. Viruses 7:5428–5442
Hoskin DW, Ramamoorthy A (2008) Studies on anticancer activities of antimicrobial peptides. Biochim Biophys Acta 1778:357–375
de la Fuente-Núñez C, Cardoso MH, de Souza Cândido E et al (2016) Synthetic antibiofilm peptides. Biochim Biophys Acta 1858:1061–1069
Mansour SC, Pena OM, Hancock REW (2014) Host defense peptides: front-line immunomodulators. Trends Immunol 35:443–450
Hilchie AL, Wuerth K, Hancock REW (2013) Immune modulation by multifaceted cationic host defense (antimicrobial) peptides. Nat Chem Biol 9:761–768
Mor A, Nguyen VH, Delfour A et al (1991) Isolation, amino acid sequence and synthesis of dermaseptin, a novel antimicrobial peptide of amphibian skin. Biochemistry (Mosc) 30:8824–8830
Durr UHN, Sudheendra US, Ramamoorthy A (2006) LL-37, the only human member of the cathelicidin family of antimicrobial peptides. Biochim Biophys Acta 1758:1408–1425
Sørensen OE, Follin P, Johnsen AH et al (2001) Human cathelicidin, hCAP-18, is processed to the antimicrobial peptide LL-37 by extracellular cleavage with proteinase 3. Blood 97:3951–3959
Sørensen OE, Gram L, Johnsen AH et al (2003) Processing of seminal plasma hCAP-18 to ALL-38 by gastricsin: a novel mechanism of generating antimicrobial peptides in vagina. J Biol Chem 278:28540–28546
Murakami M, Lopez-Garcia B, Braff M et al (2004) Postsecretory processing generates multiple cathelicidins for enhanced topical antimicrobial defense. J Immunol 172:3070–3077
Behrendt R, White P, Offer J (2016) Advances in Fmoc solid-phase peptide synthesis. J Pept Sci 22:4–27
Knappe D, Piantavigna S, Hansen A et al (2010) Oncocin (VDKPPYLPRPRPPRRIYNR-NH2): a novel antibacterial peptide optimized against gram-negative human pathogens. J Med Chem 53:5240–5247
de la Fuente-Núñez C, Reffuveille F, Mansour SC et al (2015) D-enantiomeric peptides that eradicate wild-type and multidrug-resistant biofilms and protect against lethal Pseudomonas aeruginosa infections. Chem Biol 22:196–205
Jahnsen RD, Frimodt-Moller N, Franzyk H (2012) Antimicrobial activity of peptidomimetics against multidrug-resistant Escherichia coli: a comparative study of different backbones. J Med Chem 55:7253–7261
Hilchie AL, Haney EF, Pinto DM et al (2015) Enhanced killing of breast cancer cells by a d-amino acid analog of the winter flounder-derived pleurocidin NRC-03. Exp Mol Pathol 99:426–434
Bommarius B, Jenssen H, Elliott M et al (2010) Cost-effective expression and purification of antimicrobial and host defense peptides in Escherichia coli. Peptides 31:1957–1965
Arias M, Hoffarth ER, Ishida H et al (2016) Recombinant expression, antimicrobial activity and mechanism of action of tritrpticin analogs containing fluoro-tryptophan residues. Biochim Biophys Acta 1858:1012
Panteleev PV, Ovchinnikova TV (2015) Improved strategy for recombinant production and purification of antimicrobial peptide tachyplesin I and its analogs with high cell selectivity. Biotechnol Appl Biochem. doi: 10.1002/bab.1456
Li Y, Wang J, Yang J et al (2014) Recombinant expression, purification and characterization of antimicrobial peptide ORBK in Escherichia coli. Protein Expr Purif 95:182–187
Mulder KC, de Lima LA, Aguiar PS et al (2015) Production of a modified peptide clavanin in Pichia pastoris: cloning, expression, purification and in vitro activities. AMB Express 5:46
Bellamy W, Takase M, Yamauchi K et al (1992) Identification of the bactericidal domain of lactoferrin. Biochim Biophys Acta 1121:130–136
Théolier J, Hammami R, Labelle P et al (2013) Isolation and identification of antimicrobial peptides derived by peptic cleavage of whey protein isolate. J Funct Foods 5:706–714
van der Kraan MIA, Nazmi K, Teeken A et al (2005) Lactoferrampin, an antimicrobial peptide of bovine lactoferrin, exerts its candidacidal activity by a cluster of positively charged residues at the C-terminus in combination with a helix-facilitating N-terminal part. Biol Chem 386:137–142
Jing W, Demcoe AR, Vogel HJ (2003) Conformation of a bactericidal domain of puroindoline a: structure and mechanism of action of a 13-residue antimicrobial peptide. J Bacteriol 185:4938–4947
Ibrahim HR, Thomas U, Pellegrini A (2001) A helix-loop-helix peptide at the upper lip of the active site cleft of lysozyme confers potent antimicrobial activity with membrane permeabilization action. J Biol Chem 276:43767–43774
Haney EF, Nguyen LT, Schibli DJ, Vogel HJ (2012) Design of a novel tryptophan-rich membrane-active antimicrobial peptide from the membrane-proximal region of the HIV glycoprotein, gp41. Beilstein J Org Chem 8:1172–1184
Haney EF, Hancock REW (2013) Peptide design for antimicrobial and immunomodulatory applications. Biopolymers 100:572–583
Fjell CD, Hiss JA, Hancock REW, Schneider G (2012) Designing antimicrobial peptides: form follows function. Nat Rev Drug Discov 11:37–51
Xu L, Chou S, Wang J et al (2015) Antimicrobial activity and membrane-active mechanism of tryptophan zipper-like β-hairpin antimicrobial peptides. Amino Acids 47:2385–2397
Henriksen JR, Etzerodt T, Gjetting T, Andresen TL (2014) Side chain hydrophobicity modulates therapeutic activity and membrane selectivity of antimicrobial peptide mastoparan-X. PLoS One 9:e91007
Hilpert K, Winkler DF, Hancock REW (2007) Peptide arrays on cellulose support: SPOT synthesis, a time and cost efficient method for synthesis of large numbers of peptides in a parallel and addressable fashion. Nat Protoc 2:1333–1349
Winkler DF, Hilpert K, Brandt O, Hancock REW (2009) Synthesis of peptide arrays using SPOT-technology and the CelluSpots-method. Methods Mol Biol 570:157–174
Hilpert K, Volkmer-Engert R, Walter T, Hancock REW (2005) High-throughput generation of small antibacterial peptides with improved activity. Nat Biotechnol 23:1008–1012
Cherkasov A, Hilpert K, Jenssen H et al (2009) Use of artificial intelligence in the design of small peptide antibiotics effective against a broad spectrum of highly antibiotic-resistant superbugs. ACS Chem Biol 4:65–74
Powers JPS, Hancock REW (2003) The relationship between peptide structure and antibacterial activity. Peptides 24:1681–1691
Taylor K, Barran PE, Dorin JR (2008) Structure–activity relationships in β-defensin peptides. J Pept Sci 90:1–7
Avitabile C, D’Andrea LD, Romanelli A (2014) Circular Dichroism studies on the interactions of antimicrobial peptides with bacterial cells. Sci Rep 4:4293
Bürck J, Wadhwani P, Fanghänel S, Ulrich AS (2016) Oriented circular dichroism: a method to characterize membrane-active peptides in oriented lipid bilayers. Acc Chem Res 49:184–192
Haney EF, Vogel HJ (2009) NMR of antimicrobial peptides. Ann Rep NMR Spectrosc 65:1–51
Bhunia A, Domadia PN, Torres J et al (2010) NMR structure of pardaxin, a pore-forming antimicrobial peptide, in lipopolysaccharide micelles: mechanism of outer membrane permeabilization. J Biol Chem 285:3883–3895
Peschel A, Sahl H-G (2006) The co-evolution of host cationic antimicrobial peptides and microbial resistance. Nat Rev Microbiol 4:529–536
Brogden KA (2005) Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? Nat Rev Microbiol 3:238–250
Yang L, Harroun TA, Weiss TM et al (2001) Barrel-Stave model or Toroidal model? A case study on melittin pores. Biophys J 81:1475–1485
Laver DR (1994) The barrel-stave model as applied to alamethicin and its analogs reevaluated. Biophys J 66:355–359
Leontiadou H, Mark AE, Marrink SJ (2006) Antimicrobial peptides in action. J Am Chem Soc 128:12156–12161
Sengupta D, Leontiadou H, Mark AE, Marrink S-J (2008) Toroidal pores formed by antimicrobial peptides show significant disorder. Biochim Biophys Acta 1778:2308–2317
Wu M, Maier E, Benz R, Hancock REW (1999) Mechanism of interaction of different classes of cationic antimicrobial peptides with planar bilayers and with the cytoplasmic membrane of Escherichia coli. Biochemistry 38:7235–7242
Oren Z, Shai Y (1997) Selective lysis of bacteria but not mammalian cells by diastereomers of melittin: structure-function study. Biochemistry (Mosc) 36:1826–1835
Gaspar D, Veiga AS, Castanho MARB (2013) From antimicrobial to anticancer peptides. A review. Antimicrob Resist Chemother 4:294
Gazit E, Miller IR, Biggin PC et al (1996) Structure and orientation of the mammalian antibacterial peptide cecropin P1 within phospholipid membranes. J Mol Biol 258:860–870
Hong RW, Shchepetov M, Weiser JN, Axelsen PH (2003) Transcriptional profile of the Escherichia coli response to the antimicrobial insect peptide cecropin A. Antimicrob Agents Chemother 47:1–6
Park CB, Yi KS, Matsuzaki K et al (2000) Structure-activity analysis of buforin II, a histone H2A-derived antimicrobial peptide: the proline hinge is responsible for the cell-penetrating ability of buforin II. Proc Natl Acad Sci 97:8245–8250
Zhang X, Wang Y, Liu L et al (2016) Two-peptide bacteriocin PlnEF causes cell membrane damage to Lactobacillus plantarum. Biochim Biophys Acta 1858:274–280
Mularski A, Wilksch JJ, Wang H et al (2015) Atomic force microscopy reveals the mechanobiology of lytic peptide action on bacteria. Langmuir ACS J Surf Colloids 31:6164–6171
Martin NI, Breukink E (2007) Expanding role of lipid II as a target for lantibiotics. Future Microbiol 2:513–525
Bierbaum G, Sahl HG (1985) Induction of autolysis of staphylococci by the basic peptide antibiotics Pep 5 and nisin and their influence on the activity of autolytic enzymes. Arch Microbiol 141:249–254
Milletti F (2012) Cell-penetrating peptides: classes, origin, and current landscape. Drug Discov Today 17:850–860
Guilhelmelli F, Vilela N, Albuquerque P et al (2013) Antibiotic development challenges: the various mechanisms of action of antimicrobial peptides and of bacterial resistance. Front Microbiol 4:353
Patrzykat A, Friedrich CL, Zhang L et al (2002) Sublethal concentrations of pleurocidin-derived antimicrobial peptides inhibit macromolecular synthesis in Escherichia coli. Antimicrob Agents Chemother 46:605–614
Park CB, Kim HS, Kim SC (1998) Mechanism of action of the antimicrobial peptide buforin II: buforin II kills microorganisms by penetrating the cell membrane and inhibiting cellular functions. Biochem Biophys Res Commun 244:253–257
Haney EF, Petersen AP, Lau CK et al (2013) Mechanism of action of puroindoline derived tryptophan-rich antimicrobial peptides. Biochim Biophys Acta 1828:1802–1813
Friedrich CL, Moyles D, Beveridge TJ, Hancock REW (2000) Antibacterial action of structurally diverse cationic peptides on gram-positive bacteria. Antimicrob Agents Chemother 44:2086–2092
Wiegand I, Hilpert K, Hancock RE (2008) Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances. Nat Protoc 3:163–175
Balouiri M, Sadiki M, Ibnsouda SK (2016) Methods for in vitro evaluating antimicrobial activity: a review. J Pharm Anal 6:71–79
Vojtek L, Dobes P, Büyükgüzel E et al (2014) Bioluminescent assay for evaluating antimicrobial activity in insect haemolymph. Eur J Entomol 111:335–340
Riccardi C, Nicoletti I (2006) Analysis of apoptosis by propidium iodide staining and flow cytometry. Nat Protoc 1:1458–1461
Bowdish DM, Davidson DJ, Lau YE et al (2005) Impact of LL-37 on anti-infective immunity. J Leukoc Biol 77:451–459
Lopez D, Vlamakis H, Kolter R (2010) Biofilms. Cold Spring Harb Perspect Biol 2:a000398
de la Fuente-Núñez C, Reffuveille F, Fernández L, Hancock RE (2013) Bacterial biofilm development as a multicellular adaptation: antibiotic resistance and new therapeutic strategies. Curr Opin Microbiol 16:580–589
Overhage J, Campisano A, Bains M et al (2008) Human host defense peptide LL-37 prevents bacterial biofilm formation. Infect Immun 76:4176–4182
Haney EF, Mansour SC, Hilchie AL et al (2015) High throughput screening methods for assessing antibiofilm and immunomodulatory activities of synthetic peptides. Peptides 71:276–285
de la Fuente-Núñez C, Reffuveille F, Haney EF et al (2014) Broad-spectrum anti-biofilm peptide that targets a cellular stress response. PLoS Pathog 10:e1004152
Wang G, Hanke ML, Mishra B et al (2014) Transformation of human cathelicidin LL-37 into selective, stable, and potent antimicrobial compounds. ACS Chem Biol 9:1997–2002
Reffuveille F, de la Fuente-Núñez C, Mansour S, Hancock REW (2014) A broad-spectrum anti-biofilm peptide enhances antibiotic action against bacterial biofilms. Antimicrob Agents Chemother 58:5363–5371
Lebeaux D, Chauhan A, Rendueles O, Beloin C (2013) From in vitro to in vivo models of bacterial biofilm-related infections. Pathogens 2:288–356
Ceri H, Olson ME, Stremick C et al (1999) The calgary biofilm device: new technology for rapid determination of antibiotic susceptibilities of bacterial biofilms. J Clin Microbiol 37:1771–1776
Olivares E, Badel-Berchoux S, Provot C et al (2016) The Biofilm Ring Test®: a rapid method for the routine analysis of P. aeruginosa biofilm formation kinetics. J Clin Microbiol 54:657
Merritt JH, Kadouri DE, O’Toole GA (2005) Growing and analyzing static biofilms. Curr Protoc Microbiol 22:1B11–1B118
Scott MG, Dullaghan E, Mookherjee N et al (2007) An anti-infective peptide that selectively modulates the innate immune response. Nat Biotechnol 25:465–472
Yang D, Chertov O, Oppenheim JJ (2001) Participation of mammalian defensins and cathelicidins in anti-microbial immunity: receptors and activities of human defensins and cathelicidin (LL-37). J Leukoc Biol 69:691–697
Tjabringa GS, Ninaber DK, Drijfhout JW et al (2006) Human cathelicidin LL-37 is a chemoattractant for eosinophils and neutrophils that acts via formyl-peptide receptors. Int Arch Allergy Immunol 140:103–111
Scott MG, Vreugdenhil ACE, Buurman WA et al (2000) Cutting edge: cationic antimicrobial peptides block the binding of lipopolysaccharide (LPS) to LPS binding protein. J Immunol 164:549–553
Steinstraesser L, Hirsch T, Schulte M et al (2012) Innate defense regulator peptide 1018 in wound healing and wound infection. PLoS One 7:e39373
Heilborn JD, Nilsson MF, Kratz G et al (2003) The cathelicidin anti-microbial peptide LL-37 is involved in re-epithelialization of human skin wounds and is lacking in chronic ulcer epithelium. J Invest Dermatol 120:379–389
van der Does AM, Joosten SA, Vroomans E et al (2012) The antimicrobial peptide hLF1-11 drives monocyte-dendritic cell differentiation toward dendritic cells that promote antifungal responses and enhance Th17 polarization. J Innate Immun 4:284–292
Davidson DJ, Currie AJ, Reid GS et al (2004) The cationic antimicrobial peptide LL-37 modulates dendritic cell differentiation and dendritic cell-induced T cell polarization. J Immunol 172:1146–1156
Mansour SC, de la Fuente-Núñez C, Hancock REW (2015) Peptide IDR-1018: modulating the immune system and targeting bacterial biofilms to treat antibiotic-resistant bacterial infections. J Pept Sci 21:323–329
Chen H-C (2005) Boyden chamber assay. Methods Mol Biol 294:15–22
Bowdish DME, Davidson DJ, Scott MG, Hancock REW (2005) Immunomodulatory activities of small host defense peptides. Antimicrob Agents Chemother 49:1727–1732
Hancock REW (2016) Bioinformatics: novel insights from genomic information. Nestlé Nutr Inst Workshop Ser 84:35–46
Kozłowska K, Nowak J, Kwiatkowski B, Cichorek M (1999) ESR study of plasmatic membrane of the transplantable melanoma cells in relation to their biological properties. Exp Toxicol Pathol 51:89–92
Eisenberg D, Terwilliger TC, Tsui F (1980) Structural studies of bee melittin. Biophys J 32:252–254
Lichtenstein A, Ganz T, Selsted ME, Lehrer RI (1986) In vitro tumor cell cytolysis mediated by peptide defensins of human and rabbit granulocytes. Blood 68:1407–1410
Riss TL, Moravec RA, Niles AL et al (2004) Cell viability assays. Assay Guidance Manual. Available from http://www.ncbi.nlm.nih.gov/books/NBK144065/
Smith SM, Wunder MB, Norris DA, Shellman YG (2011) A simple protocol for using a LDH-based cytotoxicity assay to assess the effects of death and growth inhibition at the same time. PLoS One 6:e26908
Mai JC, Mi Z, Kim S-H et al (2001) A proapoptotic peptide for the treatment of solid tumors. Cancer Res 61:7709–7712
Wang G (2008) Structures of human host defense cathelicidin LL-37 and its smallest antimicrobial peptide KR-12 in lipid micelles. J Biol Chem 283:32637–32643
Hwang PM, Zhou N, Shan X et al (1998) Three-dimensional solution structure of lactoferricin B, an antimicrobial peptide derived from bovine lactoferrin. Biochemistry 37:4288–4298
Rozek A, Friedrich CL, Hancock REW (2000) Structure of the bovine antimicrobial peptide indolicidin bound to dodecylphosphocholine and sodium dodecyl sulfate micelles. Biochemistry 39:15765–15774
Sawai MV, Jia HP, Liu LD et al (2001) The NMR structure of human beta-defensin-2 reveals a novel alpha-helical segment. Biochemistry 40:3810–3816
Pettersen EF, Goddard TD, Huang CC et al (2004) UCSF Chimera--a visualization system for exploratory research and analysis. J Comput Chem 25:1605–1612
Gesell J, Zasloff M, Opella SJ (1997) Two-dimensional H-1 NMR experiments show that the 23-residue magainin antibiotic peptide is an alpha-helix in dodecylphosphocholine micelles, sodium dodecylsulfate micelles, and trifluoroethanol/water solution. J Biomol NMR 9:127–135
Acknowledgments
The authors acknowledge all the members of the Hancock Lab (both past and present) for their valuable input and discussions regarding antimicrobial, antibiofilm, and immunomodulatory peptides . This work was supported by the Canadian Institutes of Health Research [funding reference number MOP-74493]. REWH holds a Canada Research Chair.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer Science+Business Media LLC
About this protocol
Cite this protocol
Haney, E.F., Mansour, S.C., Hancock, R.E.W. (2017). Antimicrobial Peptides: An Introduction. In: Hansen, P. (eds) Antimicrobial Peptides. Methods in Molecular Biology, vol 1548. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-6737-7_1
Download citation
DOI: https://doi.org/10.1007/978-1-4939-6737-7_1
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-6735-3
Online ISBN: 978-1-4939-6737-7
eBook Packages: Springer Protocols